E2F4 is required for cardiomyocyte proliferation

Cardiovascular Research

Volumn 86, Issue 1, 2010, Pages 92-102

  Van Amerongen, Machteld J ^a   Diehl, Florian ^a   Novoyatleva, Tatyana ^a   Patra, Chinmoy ^a   Engel, Felix B ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Cardiomyocyte proliferation; Cell cycle; E2F4; Kinetochore

Indexed keywords

SATELLITE DNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F4;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CENTROMERE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINESIS; HEART DEVELOPMENT; HEART MUSCLE CELL; MITOSIS; MOUSE; NEURAL CREST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; E2F2 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; HEART; HUMANS; KINETOCHORES; LAC OPERON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOSIS; MYOCYTES, CARDIAC; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77949385782     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp383     Document Type: Article

References (39)

1. Attwooll C, Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBO J 2004;23:4709-4716.
2. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 2007;19:649-657.
3. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996;16:1436-1449.
4. Magae J, Wu CL, Illenye S, Harlow E, Heintz NH. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci 1996;109:1717-1726.
5. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D. The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 1997;94:5095-5100.
6. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997;17: 7268-7282.
7. Humbert PO, Rogers C, Ganiatsas S, Landsberg RL, Trimarchi JM, Dandapani S et al. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell 2000;6:281-291.
8. Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A et al. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages. Mol Cell 2000;6:293-306.
9. Kinross KM, Clark AJ, Iazzolino RM, Humbert PO. E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 2006;108:886-895.
10. Parisi T, Bronson RT, Lees JA. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis. Oncogene 2009;28:500-508.
11. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997;94:7245-7250.
12. Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res 2005;96:509-517.
13. Gill RM, Hamel PA. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J Cell Biol 2000;148:1187-1201.
14. Wang D, Russell JL, Johnson DG. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol 2000;20: 3417-3424.
15. Puri PL, Cimino L, Fulco M, Zimmerman C, La Thangue NB, Giordano A et al. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res 1998;58:1325-1331.
16. Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA 2006;103: 15546-15551.
17. Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R. p21(CIP1) controls proliferating cell nuclear antigen level in adult cardiomyocytes. Mol Cell Biol 2003;23: 555-565.
18. Engel FB, Hauck L, Cardoso MC, Leonhardt H, Dietz R, von Harsdorf R. A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ Res 1999;85:294-301.
19. Leonhardt H, Rahn HP,Weinzierl P, Sporbert A, Cremer T, Zink D et al. Dynamics of DNA replication factories in living cells. J Cell Biol 2000;149:271-280.
20. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005;96:110-118.
21. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005;19:1175-1187.
22. Weier HU, Lucas JN, Poggensee M, Segraves R, Pinkel D, Gray JW. Two-color hybridization with high complexity chromosome-specific probes and a degenerate alpha satellite probe DNA allows unambiguous discrimination between symmetrical and asymmetrical translocations. Chromosoma 1991;100:371-376.
23. Zhou H, Li D, Song L, Liu R, Chen J, Huang X. Thr11 phosphorylated H3 is associated with centromere DNA during mitosis in MCF-7 cells. Mol Cell Biochem 2008;311: 45-50.
24. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 2004;16: 399-411.
25. MacLellan WR, Garcia A, Oh H, Frenkel P, Jordan MC, Roos KP et al. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 2005;25:2486-2497.
26. Kusek JC, Greene RM, Nugent P, Pisano MM. Expression of the E2F family of transcription factors during murine development. Int J Dev Biol 2000;44:267-277.
27. Vara D, Bicknell KA, Coxon CH, Brooks G. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem 2003;278:21388-21394.
28. Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007;87:521- 544.
29. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 1996; 28:1737-1746.
30. Deschenes C, Alvarez L, Lizotte ME, Vezina A, Rivard N. The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation. J Cell Physiol 2004;199:262-273.
31. Garneau H, Paquin MC, Carrier JC, Rivard N. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells. J Cell Physiol 2009;221:350-358.
32. Garneau H, Alvarez L, Paquin MC, Lussier C, Rancourt C, Tremblay E et al. Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells. Am J Physiol Gastrointest Liver Physiol 2007;293:G758-G772.
33. Ikeda M, Orimo H, Moriyama H, Nakajima E, Matsubara N, Mibu R et al. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res 1998;58:594-598.
34. Ebelt H, Zhang Y, Kampke A, Xu J, Schlitt A, Buerke M et al. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo. Cardiovasc Res 2008; 80:219-226.
35. von Harsdorf R, Hauck L, Mehrhof F, Wegenka U, Cardoso MC, Dietz R. E2F-1 over-expression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ Res 1999;85:128-136.
36. Flink IL, Oana S, Maitra N, Bahl JJ, Morkin E. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol 1998; 30:563-578.
37. Kirshenbaum LA, Abdellatif M, Chakraborty S, Schneider MD. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol 1996;179:402-411.
38. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007;8:379-393.
39. van Amerongen MJ, Engel FB. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 2008;12:2233-2244.